CLOs on the Move

Pliant Therapeutics

www.pliantrx.com

 
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant`s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pliantrx.com
  • 260 Littlefield Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.481.6770

Executives

Name Title Contact Details
Mike Ouimette
General Counsel and Corporate Secretary Profile
Michael Ouimette
General Counsel and Corporate Secretary Profile
Michael Ouimette
General Counsel and Corporate Secretary Profile

Similar Companies

Coldstream Laboratories

Coldstream Laboratories is a Lexington, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aegis Therapeutics

Aegis Therapeutics LLC is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Astellas Pharma Canada

Astellas Pharma Canada, Inc., a Canadian affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products.

Vera Therapeutics

Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera`s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.

Cellular Engineering Technologies

Cellular Engineering Technologies is a Iowa City, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.